Human Vaccines & Immunotherapeutics publishes international research into vaccinology and immunotherapy, including novel and experimental vaccine exploration.
Human Vaccines & Immunotherapeutics is affiliated with the International Society for Vaccines (ISV).
The aim of Human Vaccines & Immunotherapeutics is to provide a platform to present and discuss developments in vaccinology and immunotherapy. The journal covers the following topics:
- Research and development of novel vaccines and immunotherapeutics
- Experimental vaccines and novel approaches in vaccination and immunotherapy
- Vaccines and immunotherapeutics for treating non-infectious diseases, e.g., cancer
- Preclinical studies and clinical trials
- Licensed products and their use in the field
- Impact of licensed vaccines and Immunotherapeutics on disease
- Safety and perceptions of licensed vaccines
- Prevention and treatment in the developing world
- Epidemiology and pharmaco-economics
Human Vaccines & Immunotherapeutics accepts brief reports, research articles, article commentaries, meeting reports, case reports, mini reviews, product reviews, book reviews, letters to the editor and letters for publication.
Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies may be published where they will shed light on disease processes and therapies.
The journal operates a single-anonymized peer review policy.
Read the Instructions for Authors for information on how to submit your article.
*Please note that Human Vaccines & Immunotherapeutics converted to a full Open Access journal from Volume 18 (2022).
From 2022, the Print ISSN is not in active use as this journal is no longer published in print.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})